Roy H. Decker

7.5k total citations · 1 hit paper
175 papers, 4.9k citations indexed

About

Roy H. Decker is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, Roy H. Decker has authored 175 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Pulmonary and Respiratory Medicine, 65 papers in Oncology and 40 papers in Radiation. Recurrent topics in Roy H. Decker's work include Lung Cancer Diagnosis and Treatment (86 papers), Lung Cancer Treatments and Mutations (57 papers) and Advanced Radiotherapy Techniques (40 papers). Roy H. Decker is often cited by papers focused on Lung Cancer Diagnosis and Treatment (86 papers), Lung Cancer Treatments and Mutations (57 papers) and Advanced Radiotherapy Techniques (40 papers). Roy H. Decker collaborates with scholars based in United States, Türkiye and Germany. Roy H. Decker's co-authors include James B. Yu, Lynn D. Wilson, Henry S. Park, Anthony W. Kim, Shane Lloyd, Zain Husain, Christopher D. Corso, Steven Grant, Frank C. Detterbeck and Scott Gettinger and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Roy H. Decker

168 papers receiving 4.8k citations

Hit Papers

Early Assessment of Lung Cancer Immunotherapy Response vi... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
    2018 317 citations Sarah B. Goldberg, Azeet Narayan et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roy H. Decker United States 39 2.6k 2.0k 915 878 780 175 4.9k
Matthew J. Schipper United States 39 2.7k 1.1× 1.1k 0.6× 1.8k 2.0× 1.1k 1.2× 620 0.8× 235 6.0k
Jiade J. Lu China 39 2.0k 0.8× 1.5k 0.8× 750 0.8× 1.6k 1.9× 585 0.8× 186 4.5k
Masato Hareyama Japan 36 3.3k 1.3× 1.6k 0.8× 1.4k 1.5× 1.7k 2.0× 836 1.1× 178 6.2k
Yee Ung Canada 32 2.8k 1.1× 2.1k 1.1× 1.3k 1.4× 488 0.6× 880 1.1× 94 5.1k
Mohan Suntharalingam United States 38 2.2k 0.8× 1.2k 0.6× 935 1.0× 1.6k 1.8× 556 0.7× 105 4.2k
Daniel R. Gomez United States 47 4.3k 1.7× 3.1k 1.6× 2.2k 2.4× 1.6k 1.8× 815 1.0× 260 8.1k
Éric Lartigau France 34 2.0k 0.8× 946 0.5× 1.3k 1.4× 905 1.0× 513 0.7× 249 4.7k
Mathias Bressel Australia 35 1.7k 0.7× 1.4k 0.7× 1.0k 1.1× 789 0.9× 370 0.5× 184 3.8k
Marco Alloisio Italy 36 3.0k 1.2× 1.7k 0.9× 652 0.7× 843 1.0× 884 1.1× 157 4.6k
Tetsuo Akimoto Japan 29 1.6k 0.6× 1.1k 0.6× 513 0.6× 754 0.9× 497 0.6× 252 3.1k

Countries citing papers authored by Roy H. Decker

Since Specialization
Citations

This map shows the geographic impact of Roy H. Decker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy H. Decker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy H. Decker more than expected).

Fields of papers citing papers by Roy H. Decker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy H. Decker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy H. Decker. The network helps show where Roy H. Decker may publish in the future.

Co-authorship network of co-authors of Roy H. Decker

This figure shows the co-authorship network connecting the top 25 collaborators of Roy H. Decker. A scholar is included among the top collaborators of Roy H. Decker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy H. Decker. Roy H. Decker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gao, Sarah, Timothy D. Shafman, Cary P. Gross, et al.. (2022). Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC: Development and External Validation of a Multi-Institutional Model. Journal of Thoracic Oncology. 18(3). 339–349. 8 indexed citations
3.
Miccio, Joseph A., Henry S. Park, Abby White, et al.. (2021). Rates of invasive disease and outcomes in NSCLC patients with biopsy suggestive of carcinoma in situ. Lung Cancer. 157. 17–20. 4 indexed citations
4.
Daly, Megan E., Nofisat Ismaila, Roy H. Decker, et al.. (2021). Radiation Therapy for Small-Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline. Journal of Clinical Oncology. 39(8). 931–939. 40 indexed citations
5.
Jabbour, Salma K., Baerin Houghton, Andrew Robinson, et al.. (2020). Phase 3, Randomized, Placebo-Controlled Study of Stereotactic Body Radiotherapy (SBRT) with or Without Pembrolizumab in Patients with Inoperable Stage I/IIA Non–Small-Cell Lung Cancer (NSCLC): KEYNOTE-867. International Journal of Radiation Oncology*Biology*Physics. 108(3). e135–e136.
6.
Goldberg, Sarah B., Azeet Narayan, Adam J. Kole, et al.. (2018). Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA. Clinical Cancer Research. 24(8). 1872–1880. 317 indexed citations breakdown →
7.
Liu, Wu, Benjamin K. Young, Ravinder Nath, et al.. (2018). Novel Eye Plaque Designs for Brachytherapy of Iris and Ciliary Body Melanoma and the First Clinical Application. Ocular Oncology and Pathology. 5(3). 220–228. 4 indexed citations
8.
An, Yi, Henry S. Park, Jacqueline Kelly, et al.. (2017). The prognostic value of extranodal extension in human papillomavirus‐associated oropharyngeal squamous cell carcinoma. Cancer. 123(14). 2762–2772. 103 indexed citations
9.
Decker, Roy H., Sarah B. Goldberg, Sameer K. Nath, et al.. (2017). P3.02c-048 A Phase I/II Trial Evaluating the Combination of Stereotactic Body Radiotherapy and Pembrolizumab in Metastatic NSCLC. Journal of Thoracic Oncology. 12(1). S1303–S1304. 3 indexed citations
10.
Stahl, John M., Christopher D. Corso, Vivek Verma, et al.. (2016). Trends in stereotactic body radiation therapy for stage I small cell lung cancer. Lung Cancer. 103. 11–16. 72 indexed citations
11.
Rosen, Joshua E., Michelle C. Salazar, Zuoheng Wang, et al.. (2016). Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer. Journal of Thoracic and Cardiovascular Surgery. 152(1). 44–54.e9. 78 indexed citations
12.
Corso, Christopher D., et al.. (2015). The Role of Chemoradiation in Elderly Limited-Stage Small Cell Lung Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 93(3). S160–S161. 1 indexed citations
13.
Harder, Eileen M., Henry S. Park, Sameer K. Nath, B.R. Mancini, & Roy H. Decker. (2015). Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy. Practical Radiation Oncology. 5(6). e643–e649. 29 indexed citations
14.
Harder, Eileen M., et al.. (2014). Dose-Volume Parameters for the Esophagus in Pulmonary SBRT. International Journal of Radiation Oncology*Biology*Physics. 90(1). S59–S60.
15.
Combs, S.E., et al.. (2014). Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base. Journal of Thoracic Oncology. 10(2). 316–323. 109 indexed citations
16.
Johung, Kimberly L., Xiaopan Yao, Fangyong Li, et al.. (2013). A Clinical Model for Identifying Radiosensitive Tumor Genotypes in Non–Small Cell Lung Cancer. Clinical Cancer Research. 19(19). 5523–5532. 72 indexed citations
17.
Narayan, Azeet, Nicholas Carriero, Scott Gettinger, et al.. (2012). Ultrasensitive Measurement of Hotspot Mutations in Tumor DNA in Blood Using Error-Suppressed Multiplexed Deep Sequencing. Cancer Research. 72(14). 3492–3498. 142 indexed citations
18.
Yu, James B., Roy H. Decker, Frank Detterbeck, & Lynn D. Wilson. (2010). Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer. Journal of Thoracic Oncology. 5(2). 215–219. 135 indexed citations
19.
Decker, Roy H., Shujie Wang, Yun Dai, Paul Dent, & Steven Grant. (2002). Loss of the BCL-2 Phosphorylation Loop Domain Is Required to Protect Human Myeloid Leukemia Cells from Flavopiridol-Mediated Mitochondrial Damage and Apoptosis. Cancer Biology & Therapy. 1(2). 136–144. 14 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew J. Schipper Breakdown of academic impact, for papers by Jiade J. Lu Breakdown of academic impact, for papers by Masato Hareyama Breakdown of academic impact, for papers by Yee Ung Breakdown of academic impact, for papers by Mohan Suntharalingam Breakdown of academic impact, for papers by Daniel R. Gomez Breakdown of academic impact, for papers by Éric Lartigau Breakdown of academic impact, for papers by Mathias Bressel Breakdown of academic impact, for papers by Marco Alloisio Breakdown of academic impact, for papers by Tetsuo Akimoto
Rankless by CCL
2026